Thromb Haemost 2016; 115(06): 1231-1234
DOI: 10.1160/TH15-10-0798
Letters to the Editor
Schattauer GmbH

Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke

Elena Campello
1   Department of Medicine, University of Padua Medical School, Padua, Italy
,
Filippo Farina
2   Department of Neurosciences, University of Padua Medical School, Padua, Italy
,
Luca Spiezia
1   Department of Medicine, University of Padua Medical School, Padua, Italy
,
Sara Maggiolo
1   Department of Medicine, University of Padua Medical School, Padua, Italy
,
Anna Palmieri
2   Department of Neurosciences, University of Padua Medical School, Padua, Italy
,
Francesca Sartorello
1   Department of Medicine, University of Padua Medical School, Padua, Italy
,
Claudio Baracchini
2   Department of Neurosciences, University of Padua Medical School, Padua, Italy
,
Paolo Simioni
1   Department of Medicine, University of Padua Medical School, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received: 13 October 2015

Accepted after major revision: 05 February 2016

Publication Date:
27 November 2017 (online)

 

 
  • References

  • 1 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995; 333: 1581-1587.
  • 2 Hacke W, Kaste M, Fieschi C. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-1251.
  • 3 Hacke W, Kaste M, Bluhmki E. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischaemic stroke. N Engl J Med 2008; 359: 1317-1329.
  • 4 Jauch EC, Saver JL, Adams Jr. HP. et al. Guidelines for the early management of patients with acute ischaemic stroke: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2013; 44: 870-947.
  • 5 The European Stroke Organisation (ESO) Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
  • 6 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischaemic stroke. Stroke 1997; 28: 2109-2118.
  • 7 Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 2008; 79: 1093-1099.
  • 8 Lansberg MG, Thijs VN, Bammer R. et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007; 38: 2275-2278.
  • 9 Tanne D, Kasner SE, Demchuk AM. et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischaemic stroke in clinical practice: the Multicenterrt-PA Stroke Survey. Circulation 2002; 105: 1679-1685.
  • 10 Brunner F, Tomandl B, Schröter A. et al. Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation. Eur J Neurol 2011; 18: 1407-1411.
  • 11 Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
  • 12 Spiezia L, Marchioro P, Radu C. et al. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. Blood Coagul Fibrinolysis 2008; 19: 355-360.
  • 13 Vida VL, Spiezia L, Bortolussi G. et al. The coagulative profile of cyanotic children undergoing cardiac surgery: the role of whole blood preoperative thromboelastometry on postoperative transfusion requirement. Artif Organs. 2015 Epub ahead of print.
  • 14 Elliott A, Wetzel J, Pivalizza TRoper. et al. Thromboelastography in patients with acute ischaemic stroke. Int J Stroke 2015; 10: 194-201.
  • 15 Ettinger MG. Thromboelastographic studies in cerebral infarction. Stroke 1974; 05: 350-354.
  • 16 Rowe AS, Greene CL, Snider CC. et al. Thromboelastographic changes in patients experiencing an acute ischaemic stroke and receivingalteplase. J Stroke Cerebrovasc Dis 2014; 23: 1307-1311.
  • 17 Theusinger OM, Schröder CM, Eismon J. et al. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM) during major surgery with hemorrhage. Anesth Analg 2013; 117: 314-321.
  • 18 Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010; 24: 27-40.
  • 19 Solomon C, Cadamuro J, Ziegler B. et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51: 1695-1706.
  • 20 Schlimp CJ, Solomon C, Ranucci M. et al. The effectiveness of different functional fibrinogen polymerisation assays in eliminating platelet contribution to clot strength in thromboelastometry. Anesth Analg 2014; 118: 269-276.
  • 21 Theusinger OM, Wanner GA, Emmert MY. et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113: 1003-1012.
  • 22 Raza I, Davenport R, Rourke C. et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J ThrombHaemost 2013; 11: 307-314.
  • 23 Dekker SE, Viersen VA, Duvekot A. et al. Lysis onset time as diagnostic rotational thromboelastometry parameter for fast detection of hyperfibrinolysis. Anesthesiology 2014; 121: 89-97.